The UK public body has urged the use of the Manchester developed TriageHF Plus after research found it cut hospitalisations ...

agency NICE has concluded that Boston Scientific's HeartLogic and Medtronic's TriageHF diagnostics are "options for algorithm-based remote monitoring in people with cardiac implantable electronic ...

Remote monitoring for patients with implanted cardiac electrophysiology devices may finally be coming of age in the U.K. thanks to a review of these systems by the National Institute for Health and ...

Two remote monitoring tools for people diagnosed with heart failure have been approved by NICE for use in the NHS.

AI and real-time data enhance care efficiency and access. And with healthcare workers in short supply, the rapid advancements ...

Global Remote Patient Monitoring Market is estimated to be valued at $40B in 2023, expected to grow at CAGR of ~12% during the forecast period (2024 – 2030) ...

NeurAxis (NASDAQ:NRXS – Get Free Report) and Medtronic (NYSE:MDT – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength ...

"These results address an important gap in remote monitoring management of HF by ... The study was funded by Medtronic.

Fortitude Family Office LLC purchased a new stake in Medtronic plc (NYSE:MDT – Free Report) during the third quarter, ...

Boost, GPx will refine the accuracy of its debut product, CardioID, the world's first implant and needle-free remote blood monitoring solution for heart ... Sony Corporation, Jana Care, Medtronic, and ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.